Suchergebnisse - "Cioccio, Joseph"

PubPharm (9)

1

Assessment of chimerism by next generation sequencing : A comparison to STR/qPCR methods

enthalten in: Human immunology | 2024

von Brow, D. | Shike, H. | Kendrick, J. | +11

2

Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis

enthalten in: Annals of hematology | 2023

von Cioccio, J. | Rakszawski, K. | Zheng, H. | +16

3

CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia

enthalten in: Frontiers in immunology | 2023

von Zhou, H. | Jia, B. | Annageldiyev, C. | +12

4

Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis

enthalten in: Annals of hematology | 2022

von Cioccio, J. | Rakszawski, K. | Zheng, H. | +16

5

Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis

enthalten in: Annals of hematology | 2022

von Cioccio, J. | Rakszawski, K. | Zheng, H. | +16

6

Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide

enthalten in: Leukemia research | 2022

von Shah, N. | Cioccio, J. | Rakszawski, K. | +18

7

Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities

enthalten in: Bone marrow transplantation | 2022

von Pizzola, C. | Cioccio, J. | Rakszawski, K. | +12

8

Therapy of acute myeloid leukemia : therapeutic targeting of tyrosine kinases

enthalten in: Expert opinion on investigational drugs | 2019

von Cioccio, J. | Claxton, D.

9

Therapy of acute myeloid leukemia: therapeutic targeting of tyrosine kinases

enthalten in: Expert opinion on investigational drugs | 2019

von Cioccio, J. | Claxton, D.

1
[1]